Early research (Phase 1)Study completedNCT00348985
What this trial is testing
PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55